SRNE News and Press, Sorrento Therapeutics Inc. From 01/30/21

It’s like a bizarro Nifty Fifty.Robinhood (RBNHD) currently has an expanded list of 50 equities where buying shares and options contracts is limited (see full list below with recent performance). On the list, 35 are limited to one whole share (no fractional trading in these stocks) and...

Sorrento Therapeutics (NASDAQ: SRNE) is an underappreciated coronavirus stock loaded with potential. So loaded, it's poised to double and then some in value. That's the opinion of one analyst tracking the stock, Mayank Mamtani of B. Riley Securities. Friday morning, B. Riley ini...

Gainers: Lianluo Smart (LLIT) +101%, Sundial Growers (SNDL) +51%, Monopar Therapeutics (MNPR) +38%, Regional Health Properties (RHE) +20%, Conversion Labs (CVLB) +18%.Losers: Vir Biotechnology (VIR) -31%, Zymeworks ZYME -25%, American Well (AMWL) -...

Are These Top Biotech Stocks On Your Watchlist? 3 In Focus During a pandemic, the healthcare industry would normally be in the spotlight. Because of this, we have seen biotech stocks become the top performers on the stock market . Throughout 2020, many biotech companies shif...

Palm Beach, FL – January 28, 2021 – According to the National Institutes of Health (NIH), the tide in the global fight against COVID-19, the disease caused by the SARS-CoV-2 virus, may soon begin to turn. Last month, three pharmaceutical companies announced promising results f...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Sorrento Therapeutics Reports Positive Results from COVI-MSC Study Sorrento Therapeutics (NASDAQ: SRNE) rose 28% by midday after the company announced ...

Palm Beach, FL – January 27, 2021 – The antivirals market consists of sales of antiviral drugs and related services. Antiviral drugs reduce the replication of viruses at different stages. Various type of viral infections for which antiviral drugs are used include HIV, herpes, ...

Sorrento Therapeutics (SRNE) reports positive preliminary results from Phase 1b study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for patients suffering with COVID-19-induced acute respiratory distress or sy...

First three patients discharged from Hospital ICU within 8 days from initial IV administration No infusion-related adverse events noted for any patient treated to date SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- S...

Sorrento Therapeutics, Inc. (SRNE) B. Riley Virtual Oncology Conference Call January 20, 2021 14:30 ET Company Participants Henry Ji - Chairman, President & Chief Executive Officer Conference Call Participants Mayank Mamtani - B. Riley Presentation Mayank Mamtani Greetings. Thanks everyon...